Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Seamlessly bridge your LNP discovery journey from RUO to bulk GLP-tox and GMP excipient-grade material.
Explore CGMP Lipid ServicesCP-LC-0743 is an ionizable cationic lipid that has been used in the generation of lipid nanoparticles (LNPs) for the delivery of circular RNA (circRNA) and mRNA in vivo.1,2 Intramuscular administration of LNPs containing CP-LC-0743 and encapsulating circRNA encoding a luciferase reporter induces luciferase expression in mice.1 Intramuscular administration of LNPs containing CP-LC-0743 and encapsulating mRNA encoding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein induces IgG and IFN-γ production in mice.2
WARNING This product is not for human or veterinary use.
1. A complete approach for circRNA therapeutics from purification to lyophilized delivery using novel ionizable lipids. Int. J. Mol. Sci. 26(11), 5138 (2025).
2. Preserved efficacy of lyophilized SARS-